SG42375A1 - Medicinal aerosol formulation - Google Patents

Medicinal aerosol formulation

Info

Publication number
SG42375A1
SG42375A1 SG9606946A SG1996006946A SG42375A1 SG 42375 A1 SG42375 A1 SG 42375A1 SG 9606946 A SG9606946 A SG 9606946A SG 1996006946 A SG1996006946 A SG 1996006946A SG 42375 A1 SG42375 A1 SG 42375A1
Authority
SG
Singapore
Prior art keywords
aerosol formulation
medicinal aerosol
medicinal
active substance
heptafluoropropane
Prior art date
Application number
SG9606946A
Inventor
Deger Hans-Mathias
Schutz Claudia
Original Assignee
Solvay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6448287&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG42375(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Solvay filed Critical Solvay
Publication of SG42375A1 publication Critical patent/SG42375A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Abstract

A medicinal aerosol formulation which contains at least one medicinal active substance, at least one surface-active substance and pressure-liquefied heptafluoropropane as propellant is described. <IMAGE>
SG9606946A 1991-12-31 1992-12-24 Medicinal aerosol formulation SG42375A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4143263 1991-12-31

Publications (1)

Publication Number Publication Date
SG42375A1 true SG42375A1 (en) 2001-04-17

Family

ID=6448287

Family Applications (1)

Application Number Title Priority Date Filing Date
SG9606946A SG42375A1 (en) 1991-12-31 1992-12-24 Medicinal aerosol formulation

Country Status (8)

Country Link
EP (1) EP0550031B1 (en)
JP (1) JPH05279249A (en)
AT (1) ATE137666T1 (en)
CA (1) CA2086492A1 (en)
DE (1) DE59206234D1 (en)
DK (1) DK0550031T3 (en)
ES (1) ES2089357T3 (en)
SG (1) SG42375A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003270A1 (en) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg NEW SPEED GASES AND THEIR USE IN MEDICINE PREPARATIONS
EP0607822B1 (en) * 1993-01-19 1996-10-16 Hoechst Aktiengesellschaft Formulation for testing the vitality of teeth containing liquid propellants
US5679287A (en) 1995-04-28 1997-10-21 Great Lakes Chemical Corporation Uses of heptafluoropropane
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
CA2280099C (en) 1997-02-05 2005-12-27 Jago Pharma Ag Medical aerosol formulations
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
CN1158996C (en) 1998-07-24 2004-07-28 杰格研究股份公司 Medicinal aerosol for mulations
PT1102579E (en) 1998-08-04 2003-07-31 Jago Res Ag MEDICINAL AEROSOL FORMULATIONS
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
WO2000044393A2 (en) * 1999-01-29 2000-08-03 Phylomed Corporation Buccal delivery system for proteinaceous medicaments
DK1169019T3 (en) 1999-04-14 2003-06-02 Glaxo Group Ltd Pharmaceutical aerosol formulation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0384371A1 (en) * 1989-02-24 1990-08-29 Hoechst Aktiengesellschaft Aerosol container and propellant
EP0504112A2 (en) * 1991-03-14 1992-09-16 Ciba-Geigy Ag Pharmaceutical aerosol formulations
EP0518600A1 (en) * 1991-06-10 1992-12-16 Schering Corporation Non-chlorofluorocarbon aerosol formulations
EP0372777B1 (en) * 1988-12-06 1993-01-07 Riker Laboratories, Inc. Medicinal aerosol formulations

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0372777B1 (en) * 1988-12-06 1993-01-07 Riker Laboratories, Inc. Medicinal aerosol formulations
EP0384371A1 (en) * 1989-02-24 1990-08-29 Hoechst Aktiengesellschaft Aerosol container and propellant
EP0504112A2 (en) * 1991-03-14 1992-09-16 Ciba-Geigy Ag Pharmaceutical aerosol formulations
EP0518600A1 (en) * 1991-06-10 1992-12-16 Schering Corporation Non-chlorofluorocarbon aerosol formulations

Also Published As

Publication number Publication date
ATE137666T1 (en) 1996-05-15
JPH05279249A (en) 1993-10-26
EP0550031B1 (en) 1996-05-08
EP0550031A1 (en) 1993-07-07
ES2089357T3 (en) 1996-10-01
DK0550031T3 (en) 1996-08-26
CA2086492A1 (en) 1993-07-01
DE59206234D1 (en) 1996-06-13

Similar Documents

Publication Publication Date Title
EP0995434A3 (en) Medicinal aerosol formulations
CA2111002A1 (en) Non-Chlorofluorocarbon Aerosol Formulations
CA2163003A1 (en) Solubilizer and external preparations containing the same
HK130397A (en) Aerosol formulation comprising beclomethasone 17,21 dipropionate
NZ238739A (en) Aerosol formulations comprising a powdered drug, a hydrofluorocarbon propellant and a perfluoroalkylsulphonamidoalkylphosphate surface-active agent
GB2263064B (en) Aerosol drug formulations
MX9803344A (en) Stable freeze-dried pharmaceutical formulation.
NZ298169A (en) Aerosol drug formulation; comprises hydrofluoroalkane propellant, medicament for inhalation and a surfactant
SG42375A1 (en) Medicinal aerosol formulation
CA2156075A1 (en) Aerosol formulation containing a dispersing aid
CA2132512A1 (en) Bioadhesive pharmaceutical composition used for the controlled release of active ingredient
AU3038197A (en) Aerosol formulations
CA2283408A1 (en) Swallow tablet comprising paracetamol
AU525695B2 (en) Pharmaceutical formulations of prostacyclin
DK0626173T3 (en) Aerosol preparation containing fusafungin
ES2131482A1 (en) An aqueous formulation comprising bambuterol and the use thereof
EP0509098A4 (en) Ataractic
MX9707238A (en) Butixocort aerosol formulations.
GB2162746A (en) Antiacidotic medicinal agent